Accurate Drug Repositioning through Non-tissue-Specific Core Signatures from Cancer Transcriptomes
Authors:
Open Access
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 25 (2) , 523-535.e5
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (91519330, 91329302, 91749205, 31210103916)
- Chinese Academy of Sciences (XDB19020301, XDA01010303)
- Ministry of Science and Technology of the People's Republic of China (2016YFE0108700, 2015CB964803)
This publication has 36 references indexed in Scilit:
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'Nature Reviews Drug Discovery, 2017
- Functional characterization of somatic mutations in cancer using network-based inference of protein activityNature Genetics, 2016
- BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacologyNucleic Acids Research, 2015
- Promoting Health and Longevity through Diet: From Model Organisms to HumansCell, 2015
- Using networks to measure similarity between genes: association index selectionNature Methods, 2013
- The Dynamics of Signaling as a Pharmacological TargetCell, 2013
- Targeting the TGFβ signalling pathway in diseaseNature Reviews Drug Discovery, 2012
- Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel DiseaseScience Translational Medicine, 2011
- An AMPK-FOXO Pathway Mediates Longevity Induced by a Novel Method of Dietary Restriction in C. elegansCurrent Biology, 2007
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004